Pathophysiology of Streptococcus agalactiae infections in newborns;Physiopathologie des infections neonatales a Streptococcus agalactiae

Medecine Therapeutique Pediatrie

Volumn 2, Issue 1, 1999, Pages 27-31

  Poyart, Claire ^a   Trieu Cuot, Patrick ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; STREPTOCOCCUS VACCINE; VIRULENCE FACTOR;

BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CHORIOAMNIONITIS; HUMAN; MEMBRANE RUPTURE; NEWBORN INFECTION; PATHOPHYSIOLOGY; PREMATURITY; REVIEW; RISK FACTOR; STREPTOCOCCUS AGALACTIAE;

EID: 0032900195     PISSN: 12865494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Schuchat A. 1998. Epidemiology of group B streptococcal disease in the United States : shifting paradigms. Clin Microbiol Rev 11 : 497-513.
2. Wessels M.R., Kasper D.L. 1993. The changing spectrum of group B streptococcal disease. N Engl J Med 328 : 1843-1844.
3. Farley M.M., Harvey R.C., Stull T. 1993. A population-based assessment of invasive disease due to group B Streptococcus in non-pregnant adults. N Engl J Med 328 : 1807-1811.
4. Badri M.S., Zawaneh S., Cruz A.C. 1977. Rectal colonization with group B Streptococcus. Relation to vaginal colonization of pregnant women. J Infect Dis 135 : 308-312.
5. Reagan J.A., Klebanoff M.A., Nugent R.P. 1991. The epidemiology of group B streptococcal colonization in pregnancy. Obstet Gynecol 77 : 604-610.
6. Lejeune C., Maudieu P., Robin M., Nectoux M. 1986. Fréquence des infections bactériennes néonatales dans les unités de réanimations et/ou de néonatalogie. Étude multicentrique à l'aide d'un codage commun informatisé. Pédiatrie 41 : 95-104.
7. Lejeune C. 1994. Épidémiologie des infections périnatales à streptocoques du groupe B. Les Cahiers de l'AP-HP1 : 71-79.
8. Katz V., Bowes W.A. 1988. Perinatal group B streptococcal infections across intact amniotic membranes. J Reprod Med 33 : 445-449.
9. Desa D.J., Treve C.L. 1984. Intrauterine infections with group B β-haemolytic streptococci. Br J Obstet Gynaecol 91 : 237-239.
10. Ancona R.J., Ferrieri P., Williams P.P. 1980. Maternal factors that enhance the acquisition of group B streptococci by newborn infants. J Med Microbiol 13 : 273-280.
11. Chatellier S., Ramananstoa C., Harriau P., Rolland K., Rosenau A., Quentin R. 1997. Characterization of Streptococcus agalactiae strains by randomly amplified polymorphic DNA analysis. J Clin Microbiol 35 : 2573-2579.
12. Yagupsky P., Menegus M.A., Powell K.R. 1991. The changing spectrum of group B streptococcal disease in infants : an eleven-year experience in a tertiary care hospital. Pediatr Infect Dis J 10 : 801-808.
13. Baker C.J., Edwards M.S. 1990. Group B streptococcal infections. In : Remington JS, Klein JO, eds. Infectious diseases of the fetus and new-born infant. Philadelphia : WB Saunders Co : 743-811.
14. Edwards M.S., Kasper D.L., Jennings H.J., Baker C.J., Nicholson-Weller A. 1982. Capsular sialic acid prevents activation of the alternative complement pathway by type III group B streptococci. J Immunol 128 : 1278-1283.
15. Wessels M.R., Benedi V.J., Kasper D.L., Heggen L.M., Rubens C.E. 1991. Type III capsule and virulence of group B streptococci. In : Genetics and molecular biology of streptococci, lactococci, and enterococci. Washington DC : American Society for Microbiology, 219-223.
16. Martin T.R., Ruzinski J.T., Rubens C.E., Chi E.Y., Wilson C.B. 1992. The effect of type-specific polysaccharide capsule on the clearance of group B streptococci from the lungs of infant and adult rats. J Infect Dis 165 : 306-314.
17. Michel J.L., Madoff L.C., Olson K., Kling D.E., Kasper D.L., Ausubel F.M. 1992. Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. Proc Natl Acad Sci USA 89 : 10060-10064.
18. Gravekamp C., Kasper D.L., Michel J.L., Kling D.E., Carey V., Madoff L.C. 1997. Immunogenicity and protective efficacy of the alpha C protein of group B streptococci are inversely related to the number of repeats. Infect Immun 65 : 5216-5221.
19. Madoff L.C., Michel J.L., Gong E.W., Kling D.E., Kasper D.L. 1996. Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein. Proc Natl Acad Sci USA 93 : 4131-4136.
20. Jelstrom P.G., Chhatwal G.S., Timmis K.N. 1991. The IgA-binding beta antigen of the C protein complex of group B streptococci : sequence determination of its gene and detection of two binding regions. Mol Microbiol 5 : 843-849.
21. Jelstrom P.G., Talay S.R., Valentin-Weigand P., Timmis K.N., Chhatwal G.S. 1996. Identification of an immunoglobulin A binding motif located in the beta-antigen of the C protein complex of group B streptococci. Infect Immun 64 : 2787-2793.
22. Michel J.L., Madoff L.C., Kling D.E., Kasper D.L., Ausubel F.M. 1991. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect Immun 59 : 2023-2028.
23. Michel J.L., Madoff L.C., Kling D.E., Kasper D.L., Ausubel F.M. 1991. C proteins of group B streptococci. In : Genetics and molecular biology of streptococci, lactococci and enterococci. Washington DC : Américan Society for Microbiology : 214-217.
24. Madoff L.C., Michel J.L., Gong E.W., Rodewald A.K., Kasper D.L. 1992. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein. Infect Immun 60 : 4989-4994.
25. Stalhammar-Carlemaim M., Stenberg L., Lindahl G. 1993. Protein Rib : a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J Exp Med 17 : 1593-1603.
26. Wastfelt M., Stalhammar-Carlemaim M., Delisse A.M., Cabezon T., Lindahl G. 1996. Identification of a family of streptococcal surface proteins with extremely repetitive structure. J Biol Chem 271 : 18892-18897.
27. Larsson C., Stalhammar-Carlemaim M., Lindahl G. 1996. Experimental vaccination against group B Streptococcus an encapsulated bacterium with highly purified preparations of cell surface protein Rib and alpha. Infect Immun 64 : 3518-3523.
28. Bohnsack J.F., et al. 1997. A role for C5 and C5-ase in the acute neutrophil response to group B streptococcal infections. J Infect Dis 175 : 847-855.
29. DeCuenick B.J., Shockman G.D., Swenson R.M. 1982. Group B type III streptococcal cell wall : composition and structural aspects revealed through endo-N-acetylmuramidase-catalyzed hydrolysis. Infect Immun 35 : 572-582.
30. Bohnsack J.F., et al. 1992. Bacterial evasion of the antibody response : human IgG antibodies neutralize soluble but not bacteria-associated group B streptococcal C5a-ase. J Infect Dis 165 : 315-321.
31. Chmouryguina I., Suvorov A., Ferrieri P., Cleary P. 1996. Conservation of the C5a peptidase genes in group A and B streptococci. Infect Immun 64 : 2387-2390.
32. Tamura G.S., Kuyppers J.M., Smith S., Raff H., Rubens C.E. 1994. Adherence of group B streptococci to cultured epithelial cells : role of environment factors and bacterial surface components. Infect Immun 62 : 2450-2458.
33. Tamura G.S., Rubens C.E. 1995. Group B streptococci adhere to variant of fibronectin attached to a solid phase. Mol Microbiol 15 : 581-589.
34. Hulse M.L., Smith S., Chi E.Y., Pham A., Rubens C.E. 1993. Effect of type III group B streptococcal capsular polysaccharide on invasion of respiratory epithelial cells. Infect Immun 61 : 4835-4841.
35. Rubens C E., Raff H.V., Jackson J.C., Chi E.Y., Bielitzki J.T., Hillier S.L. 1991. Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation : evidence for bacterial cellular invasion. J Infect Dis 164 : 320-329.
36. Nizet V., Gibson R.L., Chi E.Y., Framson P.E., Hulse M., Rubens C.E. 1996. Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun 64 : 3818-3826.
37. Nizet V, Kim K.S., Stins M., Jonas M., Chi E.Y., Nguyen D., Rubens C.E. 1997. Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun 65 : 5074-5081.
38. Baker C.J., Rench M.A., Kasper D.L. 1990. Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection. N Engl J Med 322 : 1857-1860.
39. Kasper D.L., et al. 1996. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccin. J Clin Invest 98 : 2308-2314.
40. Marques M.B., Kasper D.L., Shroff A., Michon F., Jennings H.J., Wessels M.R. 1994. Functional activity of antibodies to group B polysaccharide of group B streptococci elicited by polysaccharide-protein conjugate vaccine. Infect Immun 62 : 1593-1599.